Mutational Landscape of HER2-low Breast Carcinoma

被引：0
|
作者：
Lukose, Georgi [1 ]
Munoz-Zuluaga, Carlos [1 ]
Munoz-Arcos, Laura [2 ]
Michaud, Olivier [2 ]
Cristofanilli, Massimo [1 ]
Hoda, Syed [3 ]
Solomon, James [1 ]
机构：
[1] New York Presbyterian Weill Cornell Med, New York, NY USA
[2] New York Presbyterian Weill Cornell Med Ctr, New York, NY USA
[3] Weill Cornell Med, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
186
引用
收藏
页码：S176 / S177
页数：2
相关论文
共 50 条
  • [31] Frequency of HER2-Low in breast cancer biopsies in Chile
    Vidal, Martin
    Rivera, Alvaro
    Schuler, Constanza
    Garnham, Nicolas
    Alcalde, Elisa
    Renner, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] TRASTUZUMAB DERUXTECAN IS EFFECTIVE IN HER2-LOW BREAST CANCER
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
  • [33] HER2-low breast cancer: insights on pathological testing
    Liu, Yueping
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [34] Genomic Alterations of Tumors in HER2-Low Breast Cancers
    Tsai, Yi-Fang
    Huang, Chi-Cheng
    Hsu, Chih-Yi
    Feng, Chin-Jung
    Lin, Yen-Shu
    Chao, Ta-Chung
    Lai, Jiun-, I
    Lien, Pei-Ju
    Liu, Chun-Yu
    Chiu, Jen-Hwey
    Tseng, Ling-Ming
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [35] HER2-low breast cancer: A new clinical entity
    Rashid, Yasmin Abdul
    Khan, Samra
    Khan, Shagufta
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (01) : 149 - 150
  • [36] HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
    Agostinetto, Elisa
    Rediti, Mattia
    Fimereli, Danai
    Debien, Veronique
    Piccart, Martine
    Aftimos, Philippe
    Sotiriou, Christos
    de Azambuja, Evandro
    CANCERS, 2021, 13 (11)
  • [37] HER2-Low Breast Cancers New Opportunities and Challenges
    Zhang, Huina
    Katerji, Hani
    Turner, Bradley M.
    Hicks, David G.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 157 (03) : 328 - 336
  • [38] Insights Into the Emerging Entity of HER2-Low Breast Cancer
    El Haddad, Georges
    Diab, Ernest
    Hajjar, Michel
    Aoun, Maroun
    Mallat, Farid
    Zalaquett, Ziad
    Kourie, Hampig-Raphael
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2024, 2024
  • [39] Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer
    Guarneri, Valentina
    Coelho, Jose Luis Passos
    Duhoux, Francois P.
    Egle, Daniel
    Garcia-Saenz, Jose angel
    Penault-Llorca, Frederique
    Selander, Katri
    Wildiers, Hans
    Zaman, Khalil
    Laeis, Petra
    Lucerna, Markus
    Pierga, Jean-Yves
    FUTURE ONCOLOGY, 2024, 20 (18) : 1237 - 1250
  • [40] Evaluation of HER2 scoring algorithms for identification of HER2-low breast cancer
    Costache, S.
    Nagy, A.
    Billingham, K.
    Haynes, H.
    Chefani, A.
    Thomas, T.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2020, 477 : S222 - S223
12345